Michelle Stempel

4.1k total citations
90 papers, 2.9k citations indexed

About

Michelle Stempel is a scholar working on Cancer Research, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Michelle Stempel has authored 90 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Cancer Research, 56 papers in Pathology and Forensic Medicine and 36 papers in Surgery. Recurrent topics in Michelle Stempel's work include Breast Cancer Treatment Studies (73 papers), Breast Lesions and Carcinomas (56 papers) and Breast Implant and Reconstruction (34 papers). Michelle Stempel is often cited by papers focused on Breast Cancer Treatment Studies (73 papers), Breast Lesions and Carcinomas (56 papers) and Breast Implant and Reconstruction (34 papers). Michelle Stempel collaborates with scholars based in United States, Switzerland and Ireland. Michelle Stempel's co-authors include Monica Morrow, Sujata Patil, Monica Morrow, Tari A. King, Anne Eaton, Emily C. Zabor, Mary L. Gemignani, Hiram S. Cody, Michelle Sampson and Melissa Pilewskie and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Michelle Stempel

90 papers receiving 2.8k citations

Peers

Countries citing papers authored by Michelle Stempel

Since Specialization

Citations

This map shows the geographic impact of Michelle Stempel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Stempel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Stempel more than expected).

Fields of papers citing papers by Michelle Stempel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Stempel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Stempel. The network helps show where Michelle Stempel may publish in the future.

Co-authorship network of co-authors of Michelle Stempel

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Stempel. A scholar is included among the top collaborators of Michelle Stempel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Stempel. Michelle Stempel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy 2020 ·Breast Cancer Research and Treatment ·Audree B. Tadros, Tracy‐Ann Moo, Michelle Stempel, Emily C. Zabor, Atif J. Khan, Monica Morrow	11
2	Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast 2019 ·Annals of Surgical Oncology ·Philip M. Spanheimer, Melissa P. Murray, Emily C. Zabor, Michelle Stempel, Monica Morrow, Kimberly J. Van Zee, Andrea V. Barrio	30
3	Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers 2019 ·Annals of Surgical Oncology ·Anita Mamtani, Emily C. Zabor, Michelle Stempel, Monica Morrow	10
4	Does Breast Density Increase the Risk of Re-excision for Women with Breast Cancer Having Breast-Conservation Therapy? 2019 ·Annals of Surgical Oncology ·Siún Walsh, Sandra Brennan, Emily C. Zabor, Laura H. Rosenberger, Michelle Stempel, (unknown), Mary L. Gemignani	10
5	Is Sentinel Lymph Node Biopsy Required for a Core Biopsy Diagnosis of Ductal Carcinoma In Situ with Microinvasion? 2019 ·Annals of Surgical Oncology ·Meghan R. Flanagan, Michelle Stempel, Edi Brogi, Monica Morrow, Hiram S. Cody	12
6	Influence of Age on the Clinical Outcome of Breast Cancer for Men and the Development of Second Primary Cancers 2018 ·Annals of Surgical Oncology ·Patricia A. Cronin, Anya Romanoff, Emily C. Zabor, Michelle Stempel, Anne Eaton, Lillian M. Smyth, Alice Y. Ho, Monica Morrow, Mahmoud El‐Tamer, Mary L. Gemignani	8
7	Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy 2018 ·Annals of Surgical Oncology ·Shirin Muhsen, Tracy‐Ann Moo, Sujata Patil, Michelle Stempel, Simon N. Powell, Monica Morrow, Mahmoud El‐Tamer	31
8	Are there patients with T1 to T2, lymph node‐negative breast cancer who are “high‐risk” for locoregional disease recurrence? 2017 ·Cancer ·Anita Mamtani, Sujata Patil, Michelle Stempel, Monica Morrow	13
9	Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer 2017 ·Annals of Surgical Oncology ·Anita Mamtani, Sujata Patil, Michelle Stempel, Monica Morrow	31
10	Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age 2016 ·Annals of Surgical Oncology ·Julia Caroline Radosa, Anne Eaton, Michelle Stempel, (unknown), Cornelia Liedtke, Erich‐Franz Solomayer, Maria Margarete Karsten, Melissa Pilewskie, Monica Morrow, Tari A. King	37
11	Estimating the OncotypeDX score: validation of an inexpensive estimation tool 2016 ·Breast Cancer Research and Treatment ·Anne Eaton, Catherine Pesce, James O. Murphy, Michelle Stempel, Sujata M. Patil, Edi Brogi, Clifford A. Hudis, Mahmoud El‐Tamer	22
12	How Beneficial is Follow-Up Mammography in Elderly Breast Cancer Survivors? 2016 ·Annals of Surgical Oncology ·(unknown), Maxine S. Jochelson, (unknown), Michelle Stempel, Monica Morrow	5
13	Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon 2016 ·Annals of Surgical Oncology ·Cindy Matsen, Kristine Villegas, Anne Eaton, Michelle Stempel, (unknown), Hiram S. Cody, Monica Morrow, Alexandra S. Heerdt	12
14	Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma? 2016 ·Annals of Surgical Oncology ·Melissa Pilewskie, Michelle Stempel, (unknown), Anne Eaton, Kimberly J. Van Zee, Monica Morrow	60
15	Axillary Node Staging for Microinvasive Breast Cancer: Is It Justified? 2012 ·Annals of Surgical Oncology ·John Lyons, Michelle Stempel, Kimberly J. Van Zee, Hiram S. Cody	30
16	Number of lymph nodes removed in sentinel lymph node‐negative breast cancer patients is significantly related to patient age and tumor size 2010 ·Cancer ·Elisa Port, Sujata Patil, Michelle Stempel, Monica Morrow, Hiram S. Cody	21
17	The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer 2010 ·The American Journal of Surgery ·(unknown), Michelle Stempel, Sujata Patil, Meier Hsu, Alice Y. Ho, Tiffany A. Traina, Monica Morrow, Hiram S. Cody, Mary L. Gemignani	10
18	Cumulative Imaging Radiation Exposure Following Breast-Conservation Therapy 2010 ·Annals of Surgical Oncology ·Jennifer L. Marti, Lawrence T. Dauer, Michelle Stempel, Sujata Patil, Jennifer B. Kaplan, Leslie L. Montgomery	3
19	Predictors of Completion Axillary Lymph Node Dissection in Patients with Positive Sentinel Lymph Nodes 2009 ·Annals of Surgical Oncology ·Amer Karam, Meier Hsu, Sujata Patil, Michelle Stempel, Tiffany A. Traina, Alice Y. Ho, Hiram S. Cody, Elisa Port, Monica Morrow, Mary L. Gemignani	5
20	Reoperative Sentinel Lymph Node Biopsy after Previous Mastectomy 2008 ·Journal of the American College of Surgeons ·Amer Karam, Michelle Stempel, Hiram S. Cody, Elisa Port	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact